Literature DB >> 20874516

Natural killer cells that respond to human immunodeficiency virus type 1 (HIV‐1) peptides are associated with control of HIV‐1 infection.

Caroline T Tiemessen1, Sharon Shalekoff, Stephen Meddows-Taylor, Diana B Schramm, Maria A Papathanasopoulos, Glenda E Gray, Gayle G Sherman, Ashraf H Coovadia, Louise Kuhn.   

Abstract

Human immunodeficiency virus (HIV)-specific natural killer (CD3- cells), CD4, and CD8 T cellular responses were determined in 79 HIV‐1-infected women in response to HIV‐1 peptide pools (Gag, Pol, Nef, Reg, and Env) with use of a whole‐blood intracellular cytokine staining assay that measures interferon-γ and/or interleukin-2. HIV‐specific CD3- cell responses to any region (Env and Reg predominantly targeted) were associated with lower viral load (P = .031) and higher CD4 T cell count (P = .015). Env‐specific CD3- cell responses were stronger in women who had both Gag CD4 and CD8 T cell responses and, in turn, was associated with lower viral load (P = .005). CD3- cell responders had significantly higher representation of CD4 T cell responses to Env and Reg (P = .012 and P = .015, respectively) and higher magnitudes of CD4 T cell responses (P = .017 and P = .037, respectively) than did nonresponders. Peptide‐specific natural killer cells are associated with markers of less severe disease progression among HIV‐1-infected women (lower viral load and higher CD4 T cell count) and with stronger HIV‐specific T cell responses.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20874516      PMCID: PMC3060333          DOI: 10.1086/656535

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  43 in total

1.  Distribution of the natural killer-related receptor for HLA-C during highly active antiretroviral therapy for human immunodeficiency virus infection.

Authors:  M C Sirianni; F Ensoli; C Alario; V Fiorelli; G Sacco; S Topino; F Iebba; I Mezzaroma; F Aiuti
Journal:  Hum Immunol       Date:  2001-12       Impact factor: 2.850

2.  CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity.

Authors:  Todd A Fehniger; Megan A Cooper; Gerard J Nuovo; Marina Cella; Fabio Facchetti; Marco Colonna; Michael A Caligiuri
Journal:  Blood       Date:  2002-12-12       Impact factor: 22.113

3.  Chemokine gene adjuvants can modulate immune responses induced by DNA vaccines.

Authors:  J J Kim; J S Yang; T Dentchev; K Dang; D B Weiner
Journal:  J Interferon Cytokine Res       Date:  2000-05       Impact factor: 2.607

4.  Innate immunity in human immunodeficiency virus infection: effect of viremia on natural killer cell function.

Authors:  Shyam Kottilil; Tae-Wook Chun; Susan Moir; Shuying Liu; Mary McLaughlin; Claire W Hallahan; Frank Maldarelli; Lawrence Corey; Anthony S Fauci
Journal:  J Infect Dis       Date:  2003-03-13       Impact factor: 5.226

5.  DNA vaccines encoding interleukin-8 and RANTES enhance antigen-specific Th1-type CD4(+) T-cell-mediated protective immunity against herpes simplex virus type 2 in vivo.

Authors:  J Sin; J J Kim; C Pachuk; C Satishchandran; D B Weiner
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

6.  Sustained impairment of IFN-gamma secretion in suppressed HIV-infected patients despite mature NK cell recovery: evidence for a defective reconstitution of innate immunity.

Authors:  Livio Azzoni; Emmanouil Papasavvas; Jihed Chehimi; Jay R Kostman; Karam Mounzer; Joe Ondercin; Bice Perussia; Luis J Montaner
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

7.  Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS.

Authors:  Maureen P Martin; Xiaojiang Gao; Jeong-Hee Lee; George W Nelson; Roger Detels; James J Goedert; Susan Buchbinder; Keith Hoots; David Vlahov; John Trowsdale; Michael Wilson; Stephen J O'Brien; Mary Carrington
Journal:  Nat Genet       Date:  2002-07-22       Impact factor: 38.330

8.  Selective depletion of CD56(dim) NK cell subsets and maintenance of CD56(bright) NK cells in treatment-naive HIV-1-seropositive individuals.

Authors:  Raquel Tarazona; Javier G Casado; Olga Delarosa; Julian Torre-Cisneros; Jose L Villanueva; Berta Sanchez; Maria D Galiani; Rafael Gonzalez; Rafael Solana; Jose Peña
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

Review 9.  Human natural killer cell receptors and co-receptors.

Authors:  R Biassoni; C Cantoni; D Pende; S Sivori; S Parolini; M Vitale; C Bottino; A Moretta
Journal:  Immunol Rev       Date:  2001-06       Impact factor: 12.988

Review 10.  Activating receptors and coreceptors involved in human natural killer cell-mediated cytolysis.

Authors:  A Moretta; C Bottino; M Vitale; D Pende; C Cantoni; M C Mingari; R Biassoni; L Moretta
Journal:  Annu Rev Immunol       Date:  2001       Impact factor: 28.527

View more
  19 in total

1.  Therapeutic envelope vaccination in combination with antiretroviral therapy temporarily rescues SIV-specific CD4⁺ T-cell-dependent natural killer cell effector responses in chronically infected rhesus macaques.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Thorsten Demberg; Ranajit Pal; Marjorie Robert-Guroff
Journal:  Immunology       Date:  2015-06       Impact factor: 7.397

2.  Human immunodeficiency virus type 1 infection is associated with increased NK cell polyfunctionality and higher levels of KIR3DL1+ NK cells in ugandans carrying the HLA-B Bw4 motif.

Authors:  Michael A Eller; Rebecca N Koehler; Gustavo H Kijak; Leigh Anne Eller; David Guwatudde; Mary A Marovich; Nelson L Michael; Mark S de Souza; Fred Wabwire-Mangen; Merlin L Robb; Jeffrey R Currier; Johan K Sandberg
Journal:  J Virol       Date:  2011-03-16       Impact factor: 5.103

3.  CCR5 promoter haplotypes differentially influence CCR5 expression on natural killer and T cell subsets in ethnically divergent HIV-1 uninfected South African populations.

Authors:  Anabela C P Picton; Maria Paximadis; Caroline T Tiemessen
Journal:  Immunogenetics       Date:  2012-08-15       Impact factor: 2.846

Review 4.  The role of interleukin-21 in HIV infection.

Authors:  Suresh Pallikkuth; Anita Parmigiani; Savita Pahwa
Journal:  Cytokine Growth Factor Rev       Date:  2012-07-02       Impact factor: 7.638

5.  Natural killer cell responses to HIV-1 peptides are associated with more activating KIR genes and HLA-C genes of the C1 allotype.

Authors:  Caroline T Tiemessen; Maria Paximadis; Gregory Minevich; Robert Winchester; Sharon Shalekoff; Glenda E Gray; Gayle G Sherman; Ashraf H Coovadia; Louise Kuhn
Journal:  J Acquir Immune Defic Syndr       Date:  2011-07-01       Impact factor: 3.731

6.  Frequent and strong antibody-mediated natural killer cell activation in response to HIV-1 Env in individuals with chronic HIV-1 infection.

Authors:  Christina F Thobakgale; Lena Fadda; Kimberly Lane; Ildiko Toth; Florencia Pereyra; Suzane Bazner; Thumbi Ndung'u; Bruce D Walker; Eric S Rosenberg; Galit Alter; Mary Carrington; Todd M Allen; Marcus Altfeld
Journal:  J Virol       Date:  2012-04-11       Impact factor: 5.103

7.  Interleukin-21 administration to rhesus macaques chronically infected with simian immunodeficiency virus increases cytotoxic effector molecules in T cells and NK cells and enhances B cell function without increasing immune activation or viral replication.

Authors:  Suresh Pallikkuth; Kenneth Rogers; Francois Villinger; Melvin Dosterii; Monica Vaccari; Genoveffa Franchini; Rajendra Pahwa; Savita Pahwa
Journal:  Vaccine       Date:  2011-10-11       Impact factor: 3.641

Review 8.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

Review 9.  Role of IL-21 and IL-21 receptor on B cells in HIV infection.

Authors:  Suresh Pallikkuth; Anita Parmigiani; Savita Pahwa
Journal:  Crit Rev Immunol       Date:  2012       Impact factor: 2.214

10.  NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model.

Authors:  Diego A Vargas-Inchaustegui; Peng Xiao; Iskra Tuero; L Jean Patterson; Marjorie Robert-Guroff
Journal:  J Immunol       Date:  2012-07-13       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.